GeoVax Labs Inc (GOVX)

[Prophet of_Profits]

GOVX plan is a nasdaq listing and a capital raise. Very positive developments if they succeeded. We would have a nasdaq stock with institutional support. Likely analyst coverage. Plenty of capital to move products through testing and into the market. Company also secured a bridge loan to get to the raise. Company now has working capital. Bridge loan very favorable. Only 5% interest. It is convertible after 6 months but the conversion price of $0.50 is above the current market price. It's also callable so might not result in any dilution. This is a real plan to build a legit nasdaq biotech. Current market cap only $5 million. Great risk reward situation.